» Articles » PMID: 12946052

General Aspects of Neurodegeneration

Overview
Date 2003 Aug 30
PMID 12946052
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases are morphologically featured by progressive cell loss in specific vulnerable neuronal populations of the central nervous system, often associated with cytoskeletal protein aggregates forming intracytoplasmic and/or intranuclear inclusions in neurons and/or glial cells. Most neurodegenerative disorders are now classified either according to the hitherto known genetic mechanisms or to the major components of their cellular protein inclusions. The major basic processes inducing neurodegeneration are considered multifactorial ones caused by genetic, environmental, and endogenous factors. They include abnormal protein dynamics with defective protein degradation and aggregation, many of them related to the ubiquitin-proteasomal system, oxidative stress and free radical formation, impaired bioenergetics and mitochondrial dysfunctions, and "neuroinflammatory" processes. These mechanisms that are usually interrelated in complex vitious circles finally leading to programmed cell death cascades are briefly discussed with reference to their pathogenetic role in many, albeit diverse neurodegenerative diseases, like Alzheimer disease, synucleinopathies, tauopathies, and polyglutamine disorders. The impact of protein inclusions on cell dysfunction, activation or prevention of cell death cascades are discussed, but the molecular basis for the underlying disease mechanisms remains to be elucidated.

Citing Articles

ISKNV Triggers AMPK/mTOR-Mediated Autophagy Signaling through Oxidative Stress, Inducing Antioxidant Enzyme Expression and Enhancing Viral Replication in GF-1 Cells.

Hsueh T, Chen P, Hong J Viruses. 2024; 16(6).

PMID: 38932206 PMC: 11209599. DOI: 10.3390/v16060914.


Interactions Between the Ubiquitin-Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence.

Monsalvo-Maraver L, Ovalle-Noguez E, Nava-Osorio J, Maya-Lopez M, Rangel-Lopez E, Tunez I Neurotox Res. 2024; 42(2):18.

PMID: 38393521 PMC: 10891226. DOI: 10.1007/s12640-024-00694-3.


The potential neuroprotective effects of stingless bee honey.

Zulkifli N, Hassan Z, Mustafa M, Wan Azman W, Hadie S, Ghani N Front Aging Neurosci. 2023; 14:1048028.

PMID: 36846103 PMC: 9945235. DOI: 10.3389/fnagi.2022.1048028.


Neuroprotective Effects of Agri-Food By-Products Rich in Phenolic Compounds.

Rojas-Garcia A, Fernandez-Ochoa A, de la Luz Cadiz-Gurrea M, Arraez-Roman D, Segura-Carretero A Nutrients. 2023; 15(2).

PMID: 36678322 PMC: 9865516. DOI: 10.3390/nu15020449.


Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?.

Carradori S, Fantacuzzi M, Ammazzalorso A, Angeli A, De Filippis B, Galati S Molecules. 2022; 27(22).

PMID: 36431918 PMC: 9694798. DOI: 10.3390/molecules27227816.